Tamsulosin HCL SR WW Pellets
Tamsulosin HCL SR WW Pellets – Sustained-Release Pellet Variant for Worldwide BPH Formulation Programs. Rraynex Tamsulosin HCL SR WW Pellets are offered as a WW variant of the Tamsulosin SR platform, maintaining sustained-release characteristics while supporting worldwide supply and capsule filling requirements.
Product overview
The WW designation supports supply programs intended for worldwide formulation and commercial distribution. Pellet processing remains focused on controlled release, particle uniformity and reproducible capsule filling. Technical specifications are available upon request.
Key characteristics
- Sustained-release WW pellet variant.
- Controlled release characteristics for BPH portfolios.
- Uniform pellet size for capsule filling.
- Support for worldwide pharmaceutical supply programs.
Product specifications
- Product
- Tamsulosin HCL SR WW Pellets
- Form
- sustained-release Pellets
- Therapeutic category
- Alpha-Blocker
- Available strengths
- 0.2%, 5%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Tamsulosin HCL SR WW Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Tamsulosin products from Rraynex
- Tamsulosin + Dutasteride — Pellets
- Tamsulosin + Dutasteride (0.4% + 0.5%) — Pellets
- Tamsulosin HCl + Tadalafil (Blended) — Pellets
- Tamsulosin HCl SR — Pellets
- Tamsulosin HCl SR + Dutasteride IR (WW) — Pellets